Medicaments pour augmenter l'érythropoïétine endogène (EPO)

• 收藏
• 分享

专利权人:

Inc.;Fibrogen

发明人:

申请号：

EP10181796.3

公开号：

EP2298301A3

申请日:

2002.12.06

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

The present invention relates to compounds for use in methods for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo. Compounds for use in methods for treating, pretreating or preconditioning, or preventing erythropoietin-associated conditions are also included.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/